Paper · 20528693

CRISPR/Cas system and its role in phage-bacteria interactions.

Deveau H and 2 others. Annu Rev Microbiol, 2010. Cited by 438 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. CRISPR/Cas system and its role in phage-bacteria interactions. Papers, record 20528693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20528693

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: CRISPR/Cas system and its role in phage-bacteria interactions.; PubMed
Journal: Annu Rev Microbiol; PubMed
Year: 2010; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/20528693/; PubMed
DOI: https://doi.org/10.1146/annurev.micro.112408.134123; PubMed
The journal: https://conductscience.org/library/journal-index/0372370; PubMed
Citations, by iCite: 438; iCite
Relative citation ratio, by iCite: 10.8; iCite
Revised in PubMed: 2024-01-04; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Deveau H	Hélène
2	Garneau JE	Josiane E
3	Moineau S	Sylvain

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Bacteria	Major topic
Bacteriophages	Major topic
Host-Parasite Interactions	Major topic
Recombination, Genetic	Major topic
Inverted Repeat Sequences
Mutagenesis, Insertional
Sequence Deletion

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by300

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 438 citations.

PMID	Title	Journal	Year	In Papers	Source
42,957,850	Planetary-scale metagenomic analysis reveals CRISPR targeting dynamics across ecosystems.	Nat Microbiol	2026	https://conductscience.org/library/papers/42957850	PubMed
42,941,856	The Role of SOD1 and Oxidative Stress in Amyotrophic Lateral Sclerosis: An Overview.	Int J Mol Sci	2026	https://conductscience.org/library/papers/42941856	PubMed
42,856,353	Bacteriophage and Antibiotic Resistance Are Positively Associated across a Phylogenetically Diverse Set of Clinical Pseudomonas aeruginosa Isolates.	bioRxiv	2026	https://conductscience.org/library/papers/42856353	PubMed
42,817,947	Surviving phage attack primes bacterial immunity to defeat counterdefenses.	bioRxiv	2026	https://conductscience.org/library/papers/42817947	PubMed
42,664,252	Proteobacteria with chemosynthetic potential are highly prevalent in the gills of Hypoplectrus reef fishes.	PLoS Genet	2026	https://conductscience.org/library/papers/42664252	PubMed
42,655,840	Development of a Visual RPA-CRISPR/Cas12a Assay Targeting Bcsp31 for Rapid Detection of Brucella spp.	Vet Sci	2026	https://conductscience.org/library/papers/42655840	PubMed
42,274,649	Use of Micro/Nanorobots In Vivo for the Eradication of Bacterial Biofilm: A Review of Challenges and Strategies.	Nanomaterials (Basel)	2026	https://conductscience.org/library/papers/42274649	PubMed
41,900,324	Identification of Phage RNA Polymerases That Minimize Double-Stranded RNA By-Product Formation and Their Characterization via In Vitro Transcription.	Microorganisms	2026	https://conductscience.org/library/papers/41900324	PubMed
41,644,849	Abasic CRISPR RNAs inherently harness fidelity of SpCas9 for genome editing.	Nat Chem Biol	2026	https://conductscience.org/library/papers/41644849	PubMed
41,460,529	Breaking barriers through driving innovation: sensitivity enhancement strategies for lateral flow assays.	Mikrochim Acta	2025	https://conductscience.org/library/papers/41460529	PubMed

1 to 10 of 300

See all 300 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
BCAR1	9,564	PubTator's text mining	https://conductscience.org/library/genes/9564

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20528693

GET https://conductscience.org/api/papers/v1/20528693/cited_by?page=2

API reference For AI assistants